Elutia (ELUT) Other Non-Current Liabilities (2019 - 2026)
Elutia (ELUT) reported Other Non-Current Liabilities of $3.4 million for Q1 2026, down 28.43% on a YoY basis from $4.7 million in Q1 2025, and up 8.48% sequentially from $3.1 million in Q4 2025.
Elutia (ELUT) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
Elutia (ELUT) has 8 years of Other Non-Current Liabilities data on file, last reported at $3.4 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities fell 28.43% year-over-year to $3.4 million; the trailing twelve-month figure through Mar 2026 stood at $3.4 million (down 28.43% YoY), and the FY2025 full-year result was $3.1 million, down 80.57% from the prior year.
- Other Non-Current Liabilities advanced to $3.4 million in Q1 2026, from $3.1 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $16.5 million in Q1 2022 to a low of $86000.0 in Q3 2022.
- A 5-year average of $5.1 million and a median of $3.4 million in 2026 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities slumped 99.48% in 2022 and soared 9947.24% in 2023, its largest moves.
- Tracing ELUT's Other Non-Current Liabilities over 5 years: stood at $127000.0 in 2022, then soared by 9947.24% to $12.8 million in 2023, then rose by 25.99% to $16.1 million in 2024, then tumbled by 80.57% to $3.1 million in 2025, then rose by 8.48% to $3.4 million in 2026.
- Business Quant data shows ELUT's Other Non-Current Liabilities at $3.4 million in Q1 2026, $3.1 million in Q4 2025, and $4.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Elutia | 39.99 Mn | 11.50 Mn | 1.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.39 Mn |
| Dec 31, 2025 | 3.12 Mn |
| Sep 30, 2025 | 4.03 Mn |
| Jun 30, 2025 | 8.97 Mn |
| Mar 31, 2025 | 4.74 Mn |
| Dec 31, 2024 | 16.08 Mn |
| Sep 30, 2024 | 6.24 Mn |
| Jun 30, 2024 | 1.57 Mn |
| Mar 31, 2024 | 7.66 Mn |
| Dec 31, 2023 | 12.76 Mn |
| Sep 30, 2023 | 433,000.00 |
| Jun 30, 2023 | 351,000.00 |
| Mar 31, 2023 | 207,000.00 |
| Dec 31, 2022 | 127,000.00 |
| Sep 30, 2022 | 86,000.00 |
| Jun 30, 2022 | 899,000.00 |
| Mar 31, 2022 | 16.52 Mn |
| Dec 31, 2021 | 698,000.00 |
| Sep 30, 2021 | 16.55 Mn |
| Jun 30, 2021 | 16.59 Mn |